Literature DB >> 10437624

Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine.

S Dryden1, M Brown, P King, G Williams.   

Abstract

Leptin inhibits feeding, stimulates thermogenesis and decreases body weight. Serotonin reduces food intake when injected into the hypothalamus and may interact with other neurotransmitters in the control of appetite. We therefore investigated the effects of the serotonergic drug fluoxetine, which inhibits serotonin reuptake, on food intake and plasma leptin levels in lean and obese Zucker rats. Fluoxetine significantly reduced food intake in lean and obese rats, both acutely after a single injection (10 mg/kg) and during continuous subcutaneous infusion (10 mg/kg/day for 7 days). Plasma leptin levels were reduced after both 4 hours and 7 days of fluoxetine administration in lean and after 7 days in fatty rats (all p<0.01). We have previously suggested that serotonin may decrease food intake by inhibiting neuropeptide Y neurones, and we further suggest that it also inhibits leptin, possibly by an effect on white adipose tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10437624     DOI: 10.1055/s-2007-978755

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  7 in total

1.  Effects of sibutramine in non-dieting obese women.

Authors:  A Gokcel; Y Gumurdulu; H Karakose; B M Karademir; R Anarat
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

2.  Hypophagia and induction of serotonin transporter gene expression in raphe nuclei of male and female rats after short-term fluoxetine treatment.

Authors:  Nuria Lauzurica; Luis García-García; José A Fuentes; Mercedes Delgado
Journal:  J Physiol Biochem       Date:  2012-06-23       Impact factor: 4.158

3.  Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels.

Authors:  Stefan Kloiber; Stephan Ripke; Martin A Kohli; Simone Reppermund; Daria Salyakina; Rudolf Uher; Peter McGuffin; Roy H Perlis; Steven P Hamilton; Benno Pütz; Johannes Hennings; Tanja Brückl; Torsten Klengel; Thomas Bettecken; Marcus Ising; Manfred Uhr; Tatjana Dose; Paul G Unschuld; Josef Zihl; Elisabeth Binder; Bertram Müller-Myhsok; Florian Holsboer; Susanne Lucae
Journal:  Eur Neuropsychopharmacol       Date:  2012-09-29       Impact factor: 4.600

4.  The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.

Authors:  P H Rauma; J A Pasco; M Berk; A L Stuart; H Koivumaa-Honkanen; R J Honkanen; J M Hodge; L J Williams
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

5.  Simultaneous administration of fluoxetine and simvastatin ameliorates lipid profile, improves brain level of neurotransmitters, and increases bioavailability of simvastatin.

Authors:  Abdulrahman K Al-Asmari; Zabih Ullah; Aqeel Salman Al Masoudi; Ishtiaque Ahmad
Journal:  J Exp Pharmacol       Date:  2017-04-11

6.  Novel Marker for Premature Ejaculation: Serum Leptin Level.

Authors:  Guodong Liu; Yuyang Zhang; Wei Zhang; Xu Wu; Hui Gao; Hui Jiang; Yutian Dai; Xiansheng Zhang
Journal:  Sex Med       Date:  2022-04-07       Impact factor: 2.523

7.  The relationship between serum leptin level and disease activity and inflammatory markers in fibromyalgia patients.

Authors:  Safinaz Ataoglu; Handan Ankarali; Rumeysa Samanci; Mustafa Ozsahin; Ozlem Admis
Journal:  North Clin Istanb       Date:  2018-04-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.